135 related articles for article (PubMed ID: 36716613)
1. Osteogenic sarcomas of the hands: A case series with emphasis in its peculiarities and literature review.
de la Guardia V; O'Meally AA; Gambarotti M; Spinnato P; Frisoni T; Cocchi S; Magagnoli G; Ibrahim T; Benini S; Pacheco M; Righi A
Pathol Res Pract; 2023 Feb; 242():154326. PubMed ID: 36716613
[TBL] [Abstract][Full Text] [Related]
2. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
3. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
4. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
[TBL] [Abstract][Full Text] [Related]
5. Low-grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw.
Sasaki A; Miyashita H; Kawaida M; Kameyama K
Clin Exp Dent Res; 2021 Dec; 7(6):1175-1182. PubMed ID: 34008925
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup.
Anninga JK; Picci P; Fiocco M; Kroon HM; Vanel D; Alberghini M; Gelderblom H; Hogendoorn PC
Virchows Arch; 2013 Jan; 462(1):109-20. PubMed ID: 23212264
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases.
Hayashi K; Tsuchiya H; Yamamoto N; Shirai T; Nishida H; Takeuchi A; Kimura H; Miwa S; Inatani H; Okamoto H; Yamada S; Ikeda H; Sawada-Kitamura S; Nojima T; Ooi A; Otsuka T
Int J Clin Oncol; 2014 Aug; 19(4):731-8. PubMed ID: 23881556
[TBL] [Abstract][Full Text] [Related]
8. [Pathomorphology of parosteal osteosarcoma. Experience with 125 cases in the Hamburg Register of Bone Tumors].
Delling G; Werner M
Orthopade; 2003 Jan; 32(1):74-81. PubMed ID: 12557089
[TBL] [Abstract][Full Text] [Related]
9. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
10. Primary osteosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 22 cases with a review of the literature.
Gadwal SR; Gannon FH; Fanburg-Smith JC; Becoskie EM; Thompson LD
Cancer; 2001 Feb; 91(3):598-605. PubMed ID: 11169944
[TBL] [Abstract][Full Text] [Related]
11. DNA cytometry of osteosarcoma.
Bauer HC
Acta Orthop Scand Suppl; 1988; 228():1-39. PubMed ID: 3063059
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
13. The ultrastructure of conventional, parosteal, and periosteal osteosarcomas.
Martínez-Tello FJ; Navas-Palacios JJ
Cancer; 1982 Sep; 50(5):949-61. PubMed ID: 6953992
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcomas in the upper distal extremities: are their oncological outcomes similar to other sites?
Pradhan A; Reddy KI; Grimer RJ; Abudu A; Tillman RM; Carter SR; Jeys L
Eur J Surg Oncol; 2015 Mar; 41(3):407-12. PubMed ID: 25442503
[TBL] [Abstract][Full Text] [Related]
17. High-grade surface osteosarcomas.
Wold LE; Unni KK; Beabout JW; Pritchard DJ
Am J Surg Pathol; 1984 Mar; 8(3):181-6. PubMed ID: 6584042
[TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
19. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
[TBL] [Abstract][Full Text] [Related]
20. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
